Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 28, 2014; 20(48): 18240-18248
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18240
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18240
Gene | HCC (n = 70) | CH (n = 30) | Control (n = 33) | P value | χ2 | |
Telomerase | +++ | 26 (37.14) | 0 (0.00) | 0 (0.00) | < 0.001 | 49.663 |
++ | 13 (18.57) | 0 (0.00) | 0 (0.00) | |||
- | 31 (44.29) | 30 (100) | 33 (100) | |||
MAGE1 | +++ | 9 (12.86) | 0 (0.00) | 0 (0.00) | < 0.001 | 55.246 |
++ | 33 (47.14) | 0 (0.00) | 0 (0.00) | |||
- | 28 (40.00) | 30 (100) | 33 (100) | |||
MAGE3 | +++ | 24 (34.29) | 0 (0.00) | 0 (0.00) | < 0.001 | 55.246 |
++ | 20 (28.57) | 0 (0.00) | 0 (0.00) | |||
- | 26 (37.14) | 30 (100) | 33 (100) |
- Citation: Bahnassy AA, Zekri ARN, El-Bastawisy A, Fawzy A, Shetta M, Hussein N, Omran D, Ahmed AAS, El-Labbody SS. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease. World J Gastroenterol 2014; 20(48): 18240-18248
- URL: https://www.wjgnet.com/1007-9327/full/v20/i48/18240.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i48.18240